Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Common Cold | 1 | 2020 | 645 | 0.54 | Why? |
| Ivermectin | 1 | 2021 | 973 | 0.45 | Why? |
| Cytomegalovirus Infections | 4 | 2018 | 667 | 0.43 | Why? |
| RNA, Messenger | 3 | 2021 | 5131 | 0.40 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.37 | Why? |
| Seasons | 2 | 2020 | 4071 | 0.35 | Why? |
| Pregnant Women | 1 | 2021 | 2535 | 0.34 | Why? |
| Roseolovirus Infections | 1 | 2008 | 131 | 0.34 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.33 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.33 | Why? |
| Herpesvirus 6, Human | 1 | 2008 | 162 | 0.32 | Why? |
| Lung Transplantation | 4 | 2018 | 1554 | 0.31 | Why? |
| Colitis | 1 | 2008 | 266 | 0.29 | Why? |
| Cytomegalovirus | 3 | 2018 | 600 | 0.26 | Why? |
| Graft Rejection | 4 | 2018 | 1766 | 0.26 | Why? |
| Sirolimus | 2 | 2018 | 240 | 0.24 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.23 | Why? |
| Mutation | 2 | 2020 | 12376 | 0.21 | Why? |
| Lyme Neuroborreliosis | 1 | 2018 | 4 | 0.19 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.19 | Why? |
| Angiofibroma | 1 | 2018 | 7 | 0.19 | Why? |
| Cervical Cord | 1 | 2018 | 26 | 0.19 | Why? |
| Encephalomyelitis | 1 | 2018 | 75 | 0.18 | Why? |
| Tuberous Sclerosis | 1 | 2018 | 63 | 0.18 | Why? |
| Facial Neoplasms | 1 | 2018 | 51 | 0.18 | Why? |
| Organ Transplantation | 3 | 2018 | 2616 | 0.17 | Why? |
| Hand, Foot and Mouth Disease | 1 | 2018 | 115 | 0.16 | Why? |
| Mannans | 1 | 2018 | 218 | 0.16 | Why? |
| Heparitin Sulfate | 1 | 2018 | 285 | 0.16 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.16 | Why? |
| Enterovirus A, Human | 1 | 2018 | 180 | 0.15 | Why? |
| Probability | 1 | 2020 | 923 | 0.15 | Why? |
| Hearing Loss, Sensorineural | 1 | 2018 | 159 | 0.15 | Why? |
| Bone and Bones | 1 | 2018 | 235 | 0.15 | Why? |
| Capsid Proteins | 1 | 2018 | 365 | 0.15 | Why? |
| Liver Failure | 1 | 2018 | 266 | 0.14 | Why? |
| Neonatal Screening | 1 | 2018 | 285 | 0.14 | Why? |
| Antibiotic Prophylaxis | 1 | 2018 | 399 | 0.14 | Why? |
| Herpesviridae Infections | 1 | 2017 | 172 | 0.14 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.13 | Why? |
| Humans | 31 | 2021 | 930598 | 0.13 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.13 | Why? |
| Switzerland | 5 | 2018 | 2738 | 0.12 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.12 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.12 | Why? |
| Patients | 1 | 2020 | 1167 | 0.12 | Why? |
| Liver Transplantation | 2 | 2018 | 2864 | 0.12 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 3832 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.11 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2018 | 634 | 0.11 | Why? |
| Clostridium Infections | 1 | 2018 | 595 | 0.10 | Why? |
| Viral Tropism | 1 | 2018 | 1329 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.10 | Why? |
| Warts | 1 | 2010 | 59 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Respiratory Tract Infections | 3 | 2018 | 6817 | 0.09 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.09 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2018 | 1234 | 0.09 | Why? |
| Laboratories | 1 | 2021 | 2858 | 0.09 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.08 | Why? |
| Transplant Recipients | 3 | 2018 | 4982 | 0.08 | Why? |
| Evolution, Molecular | 1 | 2020 | 3691 | 0.08 | Why? |
| Vitamin D | 2 | 2018 | 2904 | 0.08 | Why? |
| Zoonoses | 1 | 2020 | 3034 | 0.08 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2018 | 2309 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.07 | Why? |
| Hematologic Neoplasms | 1 | 2018 | 2105 | 0.07 | Why? |
| Skin Neoplasms | 1 | 2018 | 1679 | 0.07 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.07 | Why? |
| Graft Survival | 2 | 2018 | 587 | 0.07 | Why? |
| Kidney Transplantation | 2 | 2018 | 5397 | 0.07 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.07 | Why? |
| Virus Activation | 1 | 2008 | 480 | 0.07 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
| Virus Diseases | 2 | 2013 | 3779 | 0.06 | Why? |
| Colon | 1 | 2008 | 669 | 0.06 | Why? |
| Immunocompromised Host | 2 | 2018 | 5150 | 0.06 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.06 | Why? |
| Opportunistic Infections | 1 | 2009 | 602 | 0.06 | Why? |
| Virus Replication | 3 | 2018 | 14331 | 0.06 | Why? |
| Brain | 1 | 2018 | 5133 | 0.05 | Why? |
| Intestinal Mucosa | 1 | 2008 | 1046 | 0.05 | Why? |
| Borrelia burgdorferi Group | 1 | 2018 | 12 | 0.05 | Why? |
| Biopsy | 1 | 2008 | 2811 | 0.05 | Why? |
| Lysosome-Associated Membrane Glycoproteins | 1 | 2018 | 30 | 0.05 | Why? |
| Receptors, Scavenger | 1 | 2018 | 24 | 0.05 | Why? |
| Polymerase Chain Reaction | 2 | 2018 | 6740 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Procollagen | 1 | 2018 | 29 | 0.05 | Why? |
| Follow-Up Studies | 4 | 2018 | 17020 | 0.05 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.05 | Why? |
| Hearing Tests | 1 | 2018 | 76 | 0.05 | Why? |
| Skin Cream | 1 | 2018 | 66 | 0.04 | Why? |
| Powders | 1 | 2018 | 121 | 0.04 | Why? |
| Collagen Type I | 1 | 2018 | 56 | 0.04 | Why? |
| Bone Remodeling | 1 | 2018 | 59 | 0.04 | Why? |
| DNA, Viral | 1 | 2008 | 2521 | 0.04 | Why? |
| Emollients | 1 | 2018 | 108 | 0.04 | Why? |
| Parathyroid Hormone | 1 | 2018 | 98 | 0.04 | Why? |
| Galactose | 1 | 2018 | 201 | 0.04 | Why? |
| Tablets | 1 | 2018 | 219 | 0.04 | Why? |
| Administration, Cutaneous | 1 | 2018 | 229 | 0.04 | Why? |
| Immediate-Early Proteins | 1 | 2017 | 44 | 0.04 | Why? |
| Phosphates | 1 | 2018 | 135 | 0.04 | Why? |
| Poisson Distribution | 1 | 2018 | 348 | 0.04 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.04 | Why? |
| Female | 13 | 2021 | 380317 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.04 | Why? |
| Maternal Exposure | 1 | 2018 | 173 | 0.04 | Why? |
| Male | 15 | 2018 | 367725 | 0.04 | Why? |
| Viruses | 1 | 2009 | 2238 | 0.04 | Why? |
| Prospective Studies | 5 | 2018 | 43301 | 0.04 | Why? |
| Aspergillus | 1 | 2018 | 347 | 0.04 | Why? |
| Bone Density | 1 | 2018 | 335 | 0.04 | Why? |
| Herpesvirus 3, Human | 1 | 2017 | 228 | 0.03 | Why? |
| Influenza, Human | 2 | 2017 | 10779 | 0.03 | Why? |
| Drug Costs | 1 | 2018 | 313 | 0.03 | Why? |
| Antiviral Agents | 2 | 2018 | 41703 | 0.03 | Why? |
| Neutropenia | 1 | 2018 | 388 | 0.03 | Why? |
| Adult | 10 | 2018 | 244371 | 0.03 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.03 | Why? |
| Animals | 2 | 2020 | 78931 | 0.03 | Why? |
| HeLa Cells | 1 | 2017 | 1303 | 0.03 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.03 | Why? |
| Aged | 5 | 2020 | 215776 | 0.03 | Why? |
| Retrospective Studies | 6 | 2018 | 105322 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.03 | Why? |
| Fractures, Bone | 1 | 2018 | 487 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Immunosuppressive Agents | 1 | 2010 | 6331 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Middle Aged | 10 | 2018 | 270681 | 0.03 | Why? |
| Crowding | 1 | 2017 | 731 | 0.03 | Why? |
| Hospitalization | 3 | 2018 | 54280 | 0.03 | Why? |
| Paramyxoviridae Infections | 1 | 2013 | 364 | 0.03 | Why? |
| Incidence | 3 | 2018 | 25622 | 0.02 | Why? |
| Bronchoalveolar Lavage | 1 | 2013 | 603 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 13720 | 0.02 | Why? |
| Picornaviridae Infections | 1 | 2013 | 544 | 0.02 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.02 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.02 | Why? |
| Cross Infection | 1 | 2009 | 8675 | 0.02 | Why? |
| Workload | 1 | 2017 | 1887 | 0.02 | Why? |
| Peptides | 1 | 2018 | 2513 | 0.02 | Why? |
| Infant | 2 | 2018 | 30274 | 0.02 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2017 | 3088 | 0.02 | Why? |
| Risk Factors | 3 | 2018 | 71621 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Adolescent | 3 | 2018 | 86841 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Asymptomatic Diseases | 1 | 2013 | 3444 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Cohort Studies | 2 | 2017 | 36005 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Child | 2 | 2018 | 70012 | 0.01 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.01 | Why? |
Meylan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(174)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_